(Q44105592)

29 November 2017

title

A Phase III placebo-controlled trial of oral pilocarpine in patients undergoing radiotherapy for head-and-neck cancer (English)

1 reference

29 November 2017

main subject

phase III clinical trial

0 references

placebo

1 reference

inferred from title

placebo-controlled trial

1 reference

1 reference

11

1 reference

29 November 2017

John Waldron

6

0 references

Jolie Ringash

object named as

Jolie Ringash

9

0 references

Padraig Warde

object named as

Padraig Warde

1

0 references

Brian O'Sullivan

object named as

Brian O'Sullivan

2

0 references

author name string

Julie Aslanidis

3

1 reference

29 November 2017

Barbaranne Kroll

4

1 reference

29 November 2017

Gina Lockwood

5

1 reference

29 November 2017

David Payne

7

1 reference

29 November 2017

Andrew Bayley

8

1 reference

29 November 2017

John Kim

10

1 reference

29 November 2017

Walter Maxymiw

12

1 reference

29 November 2017

Shelley Sprague

13

1 reference

29 November 2017

Bernard J Cummings

14

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

International Journal of Radiation Oncology Biology Physics

29 November 2017

published in

1 reference

29 November 2017

volume

54

1 reference

29 November 2017

issue

1

1 reference

29 November 2017

page(s)

9-13

1 reference

A phase II study of Biotene in the treatment of postradiation xerostomia in patients with head and neck cancer

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902890-0

7 January 2021

Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902890-0

7 January 2021

Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902890-0

7 January 2021

Oral pilocarpine for radiation-induced xerostomia: integrated efficacy and safety results from two prospective randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902890-0

7 January 2021

Concomitant pilocarpine during head and neck irradiation is associated with decreased posttreatment xerostomia

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902890-0

7 January 2021

The Head and Neck Radiotherapy Questionnaire: a morbidity/quality-of-life instrument for clinical trials of radiation therapy in locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902890-0

7 January 2021

Phase III randomized trial of amifostine as a radioprotector in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902890-0

7 January 2021

A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902890-0

7 January 2021

Partial irradiation of the parotid gland

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902890-0

7 January 2021

The benefits and pitfalls of ipsilateral radiotherapy in carcinoma of the tonsillar region

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902890-0

7 January 2021

Variation in parotid gland size, configuration, and anatomic relations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902890-0

7 January 2021

CT-based parotid gland location: implications for preservation of parotid function

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902890-0

7 January 2021

Radiation-induced xerostomia: pathophysiology, clinical course and supportive treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902890-0

7 January 2021

Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902890-0

7 January 2021

Some factors influencing salivary function when treating with radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902890-0

7 January 2021

Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902890-0

7 January 2021

10.1016/S0360-3016(02)02890-0

Identifiers

DOI

1 reference

29 November 2017

1 reference